Biotechnological applications of quorum sensing inhibition as novel therapeutic strategies for multidrug resistant pathogens

Microb Pathog. 2019 Feb:127:138-143. doi: 10.1016/j.micpath.2018.11.043. Epub 2018 Nov 29.

Abstract

High incidence of antibiotic resistance among bacterial clinical isolates necessitates the discovery of new targets for inhibition of microbial pathogenicity, without stimulation of microbial resistance. This could be achieved by targeting virulence determinants, which cause host damage and disease. Many pathogenic bacteria elaborate signaling molecules for cellular communication. This signaling system is named quorum sensing system (QS), and it is contingent on the bacterial population density and mediated by signal molecules called pheromones or autoinducers (AIs). Bacteria utilize QS to regulate activities and behaviors including competence, conjugation, symbiosis, virulence, motility, sporulation, antibiotic production, and biofilm formation. Hence, targeting bacterial communicating signals and suppression of QS exhibit a fundamental approach for competing microbial communication. In this review, we illustrate the common up to date approaches to utilize QS circuits in pathogenic bacteria, including Vibrio fischeri, Pseudomonas aeruginosa, Escherichia coli and Acinetobacter baumannii, as novel therapeutic targets.

Keywords: Acinetobacter baumannii; Escherichia coli; Infectious diseases; Pseudomonas aeruginosa; Quorum sensing inhibition; Vibrio fischeri.

Publication types

  • Review

MeSH terms

  • Adaptation, Physiological / drug effects*
  • Animals
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Disease Models, Animal
  • Drug Resistance, Multiple, Bacterial*
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacteria / physiology*
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology*
  • Humans
  • Quorum Sensing / drug effects*

Substances

  • Anti-Bacterial Agents